Osteoporosis Associated with Pregnancy and Lactation

 
O
s
t
e
o
p
o
r
o
s
i
s
 
A
s
s
o
c
i
a
t
e
d
 
w
i
t
h
 
P
r
e
g
n
a
n
c
y
 
a
n
d
 
L
a
c
t
a
t
i
o
n
 
Christopher
 
Kovacs,
 
MD,
 
FRCPC,
 
FACP,
 
FACE
University
 
Research
 
Professor
Professor
 
of
 
Medicine
 
(Endocrinology),
 
Obstetrics
 
&
 
Gynecology,
 
and
 
BioMedical
 
Sciences
Faculty
 
of
 
Medicine
 
-
 
Endocrinology
Memorial
 
University
 
of
 
Newfoundland
 
D
i
s
c
l
o
s
u
r
e
 
No
 
relevant
 
conflicts
 
of
 
interest
This
 
area
 
is
 
both
 
a
 
clinical
 
interest
 
and
 
a
 
research
 
focus
 
for
 
me
 
C
a
s
e
 
P
r
e
s
e
n
t
a
t
i
o
n
 
-
 
1
 
Age
 
35
 
with
 
ankylosing
 
spondylitis,
 
treated
 
with
 
a
 
TNF
 blocker
Uneventful
 
first
 
pregnancy
 
and
 
began
 breastfeeding
 
Lactation
 
consultant
 
advised
 
that
 
baby’s
 
slow
 
weight
 
gain
 
meant
 
inadequate
 
milk
production
Instructed
 
her
 
to
 
pump
 
in
 
between
 
feeds
 
and
 
store
 
(not
 
use)
 
the
 
milk
 
(!)
Pumped
 
and
 
stored
 
as
 
much
 
milk
 
as
 
her
 
baby
 
received
 
directly
 
through
 
nursing
Two
 
months
 
into
 
breastfeeding,
 
felt
 
increasing
 
back
 
pain
Rheumatologist
 
adjusted
 
her
 
meds
 
but
 
no
 
relief
 
from
 
pain
Bent
 
over
 
to
 
move
 
her
 
baby
 
in
 
the
 
car
 
seat:
 
felt
 
and
 
heard
 
a
 
loud
 
crack
 
in
 
her
 
back
Presented
 
to
 
orthopedics
 
and
 
referred
 
to
 
endocrinology
 
in
 Calgary
 
Disclosed
when
 
I
 
saw
her
 
several
years
 
later
 
C
a
s
e
 
P
r
e
s
e
n
t
a
t
i
o
n
 
-
 
2
 
Spine
 
radiographs
 showed
compression
 
fractures
 of
30%
 
at
 
T11
 
and
 
40%
 
at
 
T12,
accompanied
 
by
 endplate
depressions
 
at
 
L2,
 
L3
 
and
 
L4
 
(These
 
radiographs
 
were
done
 
several
 
years
 
later
 
at
my
 institution)
 
C
a
s
e
 
P
r
e
s
e
n
t
a
t
i
o
n
 
-
 
3
 
Vegetarian
 
with
 
high
 
phytate
 intake
Habitual
 
calcium
 
intake
 
of
 
750
 
mg
 
daily;
 
250
 
mg
 
supplement
 
during
 
pregnancy
to
 
reach
 
1,000
 
mg
 
daily
 
(vs.
 
1,200
 
mg
 
optimal
 
intake)
Habitual
 
vitamin
 
D
 
intake
 
3,800
 
IU
 
daily
 
through
 supplements
 
Ulnar
 
fracture
 
at
 
age
 
12
 
when
 
she
 
was
 
pushed
 
down
 
on
 
the
 
schoolyard
Ankle
 
fracture
 
at
 
age
 
17
 
when
 
she
 
fell 
downstairs
Twice
 
she
 
had
 3-
week
 
courses
 
of
 
prednisone
 
for
 
asthma
 
(15
 
mg
 
starting
 dose)
Attention
 
deficit
 
hyperactivity
 
disorder,
 
postpartum
 
depression,
 
iron
 
deficiency,
mild
 
psoriasis,
 
periodic
 vertigo
Sister
 
has
 
low
 
bone
 
mass
 
(“osteopenia”)
 
but
 
no
 
fractures
 
Determined
when
 
I
 
saw
her
 
several
years
 
later
 
C
a
s
e
 
P
r
e
s
e
n
t
a
t
i
o
n
 
-
 
4
 
Workup
 
for
 
secondary
 
causes
 
of
 
bone
 
loss
 
was
 
otherwise
 unremarkable
Whole
 
genome
 
sequencing
 
found
 
no
 
mutations
 
in
 
any
 
genes
 
related
 
to
osteoporosis,
 
bone
 
mass,
 
or
 
bone
 
metabolism
At
 
6
 
months
 
postpartum,
 
while
 
still
 
breastfeeding,
 
Lunar
 
DXA
 
revealed
 severe
bone
 
loss
 
at
 
the
 
lumbar
 spine:
Lumbar
 
spine
 
0.645
 
g/cm
2
 
or
 
Z-score
 
-
3.6
Total
 
hip
 
0.736
 
g/cm
2
 
or
 
Z-score
 
-
1.6
Femoral
 
neck
 
0.542
 
g/cm
2
 
or
 
Z-score
 
-
2.6
At
 
8
 
months
 
postpartum,
 
HR-
pQCT
 
showed
 
very
 
low
 
trabecular
 
bone
 
volumes
in
 
the
 
left
 
radius
 
and
 
tibia
 
P
r
e
g
n
a
n
c
y
 
M
i
n
e
r
a
l
 
d
e
m
a
n
d
s
 
d
u
r
i
n
g
 
p
r
e
g
n
a
n
c
y
 
Average
 
human
 
fetus
 
at
 
term
 
has:
30
 
g
 
of
 
calcium
20
 
g
 
of
 
phosphorus
0.8
 
g
 
of
 
magnesium
 
80%
 
is
 
accreted
 
during
 
the
 
third
 trimester
 
The
 
rate
 
of
 
accretion
 
averages
 
150
 
mg
 
calcium
 
per
 
kg
 
fetal
 
weight
 
daily
60
 
mg
 
per
 
day
 
at
 
week
 
24
300-
350
 
mg
 
per
 
day
 
between the
 
35th
 
and
 
40th 
weeks
 
Kovacs
 
CS.
 
Physiol
 
Rev
 
2016;
 
96:449-
547
 
T
h
e
 
p
o
t
e
n
t
i
a
l
 
c
a
l
c
i
u
m
 
d
e
f
i
c
i
t
 
Recommended
 
calcium
 
intake
 (non-
pregnant
 
or
 
pregnant)
 
is
 
1,200
 
mg
 
per
 
day
 
In
 
reproductive
 
age
 
North
 
American
 
women:
50
th
 
percentile
 
of
 
calcium
 
intake
 
is
 
~800-1,000
 
mg
 
daily
 
(varying
 
by
 
age
 
and
 
ethnicity)*
~25%
 
of
 
dietary
 
calcium
 
is
 
absorbed
Net
 
absorption
 
is
 
200-250
 
mg
 
of
 
calcium
 
This
 
is
 
insufficient
 
to
 
meet
 
the
 
fetal
 
demands
 
in
 
the
 
third
 
trimester,
 
and
 
well
below
 
the
 
combined
 
requirements
 
of
 
mother
 
and
 fetus
Assuming
 
25%
 
absorption,
 
would
 
require
 
an
 
extra
 
1,400
 
mg
 
daily
 
to
 
provide
 
the
 
350
 
mg
 
the
 
fetus
 
needs
 
during
 
the
 
late
 
third
 
trimester
 
Kovacs
 
CS.
 
Physiol
 
Rev
 
2016;
 
96:449-
547
 
Institute
 
of
 
Medicine,
 
Dietary
 
Reference
 
Intakes
 
for
 
Calcium
 
and
 
Vitamin
 
D,
 
2011
*NHANES
 
and
 
Health
 
Canada
 
data
 
M
a
t
e
r
n
a
l
 
a
d
a
p
t
a
t
i
o
n
s
 
d
u
r
i
n
g
 
p
r
e
g
n
a
n
c
y
 
80%
 
of
 
calcium
 
is
 
actively
 
transported
to
 
the
 
fetus
 
in
 
third
 trimester
 
Doubling
 
of
 
intestinal 
calcium
absorption
 
begins
 
in
 
1st
 trimester
Calcium
 
balance
 
studies
 
predict
 maternal
skeletal
 
mineral
 
content
 
must
 
be
 increased
during
 
the
 
first
 
half
 
of
 pregnancy
 
 
Concurrent
 
2
 
to
 5-
fold
 
increase
 
in
calcitriol
 
(active
 
vitamin
 
D)
 
Kovacs
 
CS.
 
Physiol
 
Rev
 
2016;
 
96:449-
547
 
Urine
 
Serum
 
Ca
++
 
Calcium
Intake
 
Kovacs
 
CS
 
and
 
Kronenberg
 
HM.
 
Endocr
 
Rev
 
1997;
 
18:832-
872
 
P
r
e
g
n
a
n
c
y
 
Serum
 
calcium
 
falls
 
due
 
to
 albumin
Ionized
 
calcium
 
normal
PTH
 
low
*
Calcitriol
 
increases
 
2
 
to
 
5-
fold
PTHrP
 
increases
 steadily
Estradiol
 
increases
 
up
 
to
 
100x
Calcitonin
 
increased
 
Intestinal
 
calcium
 
absorption
 
doubled
 
*exception:
 
women
 
from
 
Asia
 
and
 
Africa
 
with
very
 
low
 
calcium
 
or
 
high
 
phytate
 
intakes
PTHrP
 
=
 
PTH-
related
 
protein
 
M
a
t
e
r
n
a
l
 
k
i
d
n
e
y
s
 
 
n
o
t
 
p
l
a
c
e
n
t
a
 
 
a
r
e
 
t
h
e
 
s
o
u
r
c
e
 
o
f
c
a
l
c
i
t
r
i
o
l
 
d
u
r
i
n
g
 
p
r
e
g
n
a
n
c
y
 
i
n
 
r
o
d
e
n
t
s
 
a
n
d
 
w
o
m
e
n
 
Anephric
 
women
 
have
 
low,
unchanging
 
calcitriol
 before
and
 
during
 
pregnancy
1
 
In
 
mice,
 
maternal
 
absence
 
of
Cyp27b1
 
(the
 
enzyme
 
that
creates
 
calcitriol)
 
obliterates
the
 
rise
 
in
 calcitriol
2
 
1
Turner
 
M.
 
Miner
 
Electrolyte
 
Metab
 
1988;
 
14:246-
252
2
Gillies
 
B.
 
J
 
Bone
 
Miner
 
Res
 
2018;
 
33:16-
26
 
C
a
l
c
i
t
r
i
o
l
 
i
n
c
r
e
a
s
e
s
 
d
u
r
i
n
g
 
p
r
e
g
n
a
n
c
y
 
w
i
t
h
o
u
t
 
P
T
H
 
Inferred
 
that
 
calcitriol
 
rises
 
during
pregnancy
 
in
 
hypoparathyroid
women
 
in
 
whom
 
supplemental
calcitriol
 
needs
 
are
 
reduced
 
or
eliminated
 
Confirmed
 
in
 
aparathyroid
 
rodents,
including
 
mice
 
lacking
 
the
 
gene
encoding
 
PTH
 
Sweeney
 
L.
 
Endocr
 
Pract
.
 
2010;
 
16:459-
462
Kovacs
 
CS.
 
Physiol
 
Rev
 
2016;
 
96:449-
547
Kirby
 
BJ.
 
J
 
Bone
 
Mineral
 
Res
 
2013;
 
28:1987-
2000
 
I
n
t
e
s
t
i
n
a
l
 
c
a
l
c
i
u
m
 
a
b
s
o
r
p
t
i
o
n
 
i
n
c
r
e
a
s
e
s
 
d
u
r
i
n
g
 
p
r
e
g
n
a
n
c
y
i
n
 
r
o
d
e
n
t
s
 
w
i
t
h
o
u
t
 
c
a
l
c
i
t
r
i
o
l
,
 
V
D
R
,
 
o
r
 
v
i
t
a
m
i
n
 
D
 
Kovacs
 
CS.
 
Physiol
 
Rev
 
2016;
 
96:449-
547
Ryan
 
BA.
 
J
 
Bone
 
Miner
 
Res
 
2022;
 
36:
 
2483-
2497
 
K
e
y
 
p
o
i
n
t
s
 
a
b
o
u
t
 
p
r
e
g
n
a
n
c
y
 
The
 
fetal
 
demand
 
for
 
mineral
 
is
 
met
 
by
 
increased
 
intestinal
 
absorption
But
 
if
 
net
 
calcium
 
intake
 
is
 
low,
 
the
 
maternal
 
skeleton
 
must
 
be
 
resorbed
 
The
 
increase
 
in
 
calcium
 
absorption
 
is
 
driven
 
in
 
part
 
by
 
an
 
increase
 
in
 
calcitriol,
but
 
it’s
 
also
 
driven
 
by
 
unknown
 
factors
 
independent
 
of
 calcitriol
More
 
than
 
one
 
mechanism
 
kicks
 
in
 
to
 
ensure
 
calcium
 
delivery
Consequently,
 
calcium
 
delivery
 
is
 
maintained
 
despite
 
severe
 
vitamin
 
D
 
deficiency
 
C
a
u
s
e
s
 
o
f
 
s
k
e
l
e
t
a
l
 
f
r
a
g
i
l
i
t
y
 
a
s
s
o
c
i
a
t
e
d
 
w
i
t
h
 
p
r
e
g
n
a
n
c
y
 
Nutritional
Low
 
dietary
 
calcium
 
intake
Dairy
 
avoidance
Lactose
 
intolerance
Low
 
vitamin
 
D
 
intake/vitamin
 
D
 
deficiency
High
 
phytate
 
intake
Anorexia
 
nervosa
 
Gastrointestinal
Celiac
 
disease
Crohn’s
 
disease
Cystic
 
fibrosis
Short
 
bowel
 
from
 
resections
Other
 
malabsorptive
 
disorders
 
Hormonal
Excess
 
PTHrP
 
from
 
placenta
 
or
 
breasts*
Primary
 
hyperparathyroidism
Hyperthyroidism
Cushing’s
 
syndrome
Chronic
 
oligoamenorrhea
Hypothalamic
 
amenorrhea
Pituitary
 
disorders
 
leading
 
to
 
sex
 
steroid
deficiency
Premature
 
ovarian
 
failure
 
Kovacs
 
CS
 
and
 
Ralston
 
SH.
 
Osteoporos
 
Int
 
2015;
 
26:2223-
2241
 
*each
 
source
 
has
 
also
 
been
 
found
 
to
 
cause
hypercalcemia
 
in
 
pregnancy
 
C
a
u
s
e
s
 
o
f
 
s
k
e
l
e
t
a
l
 
f
r
a
g
i
l
i
t
y
 
a
s
s
o
c
i
a
t
e
d
 
w
i
t
h
 
p
r
e
g
n
a
n
c
y
 
Mechanical
Petite
 
frame
Low
 
body
 
weight
Low
 
peak
 
bone
 
mass
Excess
 
exercise
Increased
 
weight-
bearing
 
of
 
pregnancy
Lordotic
 
posture
 
of
 
pregnancy
Bedrest
Incomplete
 
recovery
 
from
 
prior
 
lactation?
 
Renal
Hypercalciuria/renal
 
calcium
 
leak
Chronic
 
renal
 
insufficiency
Renal
 
tubular
 
acidosis
 
Pharmacological
GnRH
 
analog
 
treatment
Progestin-
only
 
contraceptives
Glucocorticoids
Proton
 
pump
 
inhibitors
Heparin
Certain
 
anti-
seizure
 
medications
 
(phenytoin,
carbamazepine)
Cancer
 
chemotherapy
Alcohol
 
Kovacs
 
CS
 
and
 
Ralston
 
SH.
 
Osteoporos
 
Int
 
2015;
 
26:2223-
2241
 
C
a
u
s
e
s
 
o
f
 
s
k
e
l
e
t
a
l
 
f
r
a
g
i
l
i
t
y
 
a
s
s
o
c
i
a
t
e
d
 
w
i
t
h
 
p
r
e
g
n
a
n
c
y
 
Primary
 
disorders
 
of
 
bone
 
quality*
Osteogenesis
 
imperfecta
 
(COL1A1/1A2
mutations)
 
 
milder
 
forms
Osteopetrosis
 
and
 
other
 
sclerosing
 
bone
disorders
LRP5
 
inactivating
 
mutations
Wnt1
 
mutations
 
Connective
 
tissue
 
disorders
Ehlers-
Danlos
 
syndrome
Marfan
 
syndrome
 
*not
 
known
 
prior
 
to
 
pregnancy
 
Rheumatological
 
disorders
Rheumatoid
 
arthritis
Systemic
 
lupus
 
erythematosis
 
Other
 
non-
specified
 
genetic
 
disorders
Family
 
history
 
of
 
osteoporosis
 
or
 
skeletal
fragility
Positive
 
genetic
 
screen
 
for
 
other
 
bone
disorders
 
Idiopathic
 
osteoporosis
 
Being
 
a
 
primipara
 
Kovacs
 
CS
 
and
 
Ralston
 
SH.
 
Osteoporos
 
Int
 
2015;
 
26:2223-
2241
 
O
s
t
e
o
p
o
r
o
s
i
s
 
p
r
e
s
e
n
t
i
n
g
 
d
u
r
i
n
g
 
p
r
e
g
n
a
n
c
y
 
Occasionally
 
vertebral
 
crush
 
fractures
 
occur
 
during
 
late
 
pregnancy
Exact
 
frequency
 unknown
Back
 
pain
 
is
 
common
 
during
 
pregnancy;
 
compression
 
fractures
 
may
 
be
 
overlooked
Some
 
evidence
 
that
 
appendicular
 
fractures
 
may
 
be
 
more
 
common
1
Baseline
 
or
 pre-
pregnancy
 
bone
 
mineral
 
density
 
(BMD)
 
usually
 
unknown
May
 
be
 
due
 
to
 
a
 
combination
 
of
 
factors
 
shown
 
on
 
preceding
 
three
 slides
 
Recommend
 
(my
 
opinion):
Conservative
 
management
 
and
 
postpartum
 
investigations
 
into
 
bone
 
health
Expect
 
a
 
spontaneous
 
postpartum
 
increase
 
in
 
BMD
 
by
 
10-
20%
May
 
be
 
advisable
 
to
 
avoid
 breastfeeding
 
1
 
Herath
 
M.
 
Arch
 
Osteoporos
 
2017;
 
12:
 
86
Kovacs
 
CS
 
and
 
Ralston
 
SH.
 
Osteoporos
 
Int
 
2015;
 
26:2223-
2241
 
S
e
p
a
r
a
t
e
 
d
i
s
o
r
d
e
r
:
 
t
r
a
n
s
i
e
n
t
 
o
s
t
e
o
p
o
r
o
s
i
s
 
o
f
 
t
h
e
 
h
i
p
A
K
A
 
l
o
c
a
l
i
z
e
d
 
o
r
 
r
e
g
i
o
n
a
l
 
m
i
g
r
a
t
o
r
y
 
o
s
t
e
o
p
o
r
o
s
i
s
;
 
b
o
n
e
 
m
a
r
r
o
w
 
e
d
e
m
a
 
s
y
n
d
r
o
m
e
 
Not
 
due
 
to
 
systemic
 
resorption
 
of
 
the
 skeleton
A
 
form
 
of
 
chronic
 
regional
 
pain
 
syndrome
 
type
 
I
 
or
 
reflex
 
sympathetic
 dystrophy
Can
 
occur
 
equally in
 
men and
 
non-
pregnant
 
women
Women
 
present
 
during
 
the
 
third
 
trimester
 
or
 
early
 
postpartum
 
with
 
hip
 
pain,
limp,
 
or
 
hip
 
fracture;
 
occasionally,
 
both
 
hips
 
are
 involved
Radiographs
 
show
 
osteopenia
 
and
 
radiolucency
 
of
 
femoral
 
head
 
and
 
neck
DXA
 
shows
 
low
 
hip
 
BMD
 
whereas
 
spine
 
is
 
normal
 
or
 
not
 
as
 
reduced
MRI
 
shows
 
edema
 
of
 
femoral
 
head
 
and
 
marrow
DXA
 
and
 
MRI
 
findings
 
typically
 
resolve
 
within
 
2
 
to
 
12
 
months;
 
BMD
 
may
increase by
 
20-
40%
 
Kovacs
 
CS
 
and
 
Ralston
 
SH.
 
Osteoporos
 
Int
 
2015;
 
26:2223-
2241
 
L
a
c
t
a
t
i
o
n
 
L
a
c
t
a
t
i
o
n
 
Neonate
 
requires
 
an
 
average
 
of
 
210
 
mg
 
of
 
calcium
 
daily
 
through
 
milk
 
during
the
 
first
 
six
 months
Between
 
6
 
to
 
12
 
months
 
the
 
infant
 
requires
 
about
 
260
 
mg
 
of
 
calcium
 daily
120
 
mg
 
per
 
day
 
from
 
milk
140
 
mg
 
from
 
solid
 
foods
Nursing
 
twins
 
or
 
triplets
 
respectively
 
doubles
 
and
 
triples
 
the
 
maternal
 
calcium
output
Maternal
 
intake
 
and
 
absorption
 
of
 
calcium
 
is
 
typically
 
insufficient
 
to
 
meet
 
the
demands
 
of
 
milk
 
production
 
but
 
it
 
doesn’t
 matter
 
Kovacs
 
CS.
 
Physiol
 
Rev
 
2016;
 
96:449-
547
 
M
a
t
e
r
n
a
l
 
a
d
a
p
t
a
t
i
o
n
s
 
d
u
r
i
n
g
 
l
a
c
t
a
t
i
o
n
 
Temporary
 
loss
 
of
 
bone
 
mineral
 
to
provide
 
~210
 
mg
 
calcium
 
daily
 
to
 
milk
5-
10%
 
loss
 
of
 
BMD in 
2-
6
 
months 
for
women
trabecular
 
>
 
cortical
vertebral
 
>
 
appendicular
 
Renal
 
calcium
 conservation
 
Intestinal
 
calcium
 
absorption
 
is
 
normal
(non-
pregnant
 
rate)
 
Kovacs
 
CS.
 
Physiol
 
Rev
 
2016;
 
96:449-
547
 
G
r
e
a
t
e
r
 
d
e
c
l
i
n
e
 
i
n
 
B
M
D
 
w
i
t
h
 
l
o
n
g
e
r
 
d
u
r
a
t
i
o
n
 
o
f
 
l
a
c
t
a
t
i
o
n
 
More
 
C.
 
Osteoporos
 
Int
 
2001;
 
12:732-
737
 
R
a
n
d
o
m
i
z
e
d
 
i
n
t
e
r
v
e
n
t
i
o
n
:
 
1
 
g
r
a
m
 
o
f
 
s
u
p
p
l
e
m
e
n
t
a
l
c
a
l
c
i
u
m
 
d
o
e
s
 
n
o
t
 
p
r
e
v
e
n
t
 
l
a
c
t
a
t
i
o
n
a
l
 
b
o
n
e
 
l
o
s
s
 
Kalkwarf
 
H.
 
N
 
Engl
 
J
 
Med
 
1997;
 
337:523-
8.
 
Urine
Breast
 
Milk
 
Serum
 
Ca
++
 
Calcium
Intake
 
L
a
c
t
a
t
i
o
n
 
Serum
 
calcium
 
normal
Ionized
 
calcium
 
normal
 
or
 
slightly
increased
PTH
 
low
Calcitriol
 
normal
PTHrP
 
increased
Calcitonin
 
increased
 
for
 
first
 
six
weeks,
 
then
 
normalizes
Estradiol
 
low
Prolactin
 
elevated
 
Kovacs
 
CS
 
and
 
Kronenberg
 
HM.
 
Endocr
 
Rev
 
1997;
 
18:832-
872
 
Ca
2+
 
Ca
2+
Ca
2+
Ca
2+
 
Ca
2+
Ca
2+
Ca
2+
 

 
GnRH

 
LH,
 

 
FSH
 

 
E
2
,
 

 
PROG
PTHrP
 
Kovacs
 
CS.
 
J
 
Mammary
 
Gland
 
Biol
 
Neoplasia
 
2005;
 
10:105-
118
 
PTHrP
 
and
 
low
 
estradiol
(and
 
possibly
 
additional
factors)
 
drive
 
bone
resorption
 
during
 
lactation
 
B
r
a
i
n
,
 
b
r
e
a
s
t
 
a
n
d
 
b
o
n
e
 
c
i
r
c
u
i
t
 
O
T
P
R
L
 
C
T
 
CT
 
=
 
calcitonin
E
2
=
 
estradiol
OT
 
=
 
oxytocin
PRL
 
=
 
prolactin
PROG
 
=
 
progesterone
 
H
o
r
m
o
n
a
l
 
c
h
a
n
g
e
s
 
d
r
i
v
e
 
o
s
t
e
o
c
l
a
s
t
-
m
e
d
i
a
t
e
d
 
b
o
n
e
r
e
s
o
r
p
t
i
o
n
 
a
n
d
 
o
s
t
e
o
c
y
t
i
c
 
o
s
t
e
o
l
y
s
i
s
 
Ryan
 
BA
 
and
 
Kovacs
 
CS.
 
J
 
Clin
 
Invest
 
2019;
 
129:
 
3041-
3044
 
O
s
t
e
o
c
y
t
i
c
 
o
s
t
e
o
l
y
s
i
s
 
c
o
n
t
r
o
l
s
o
s
t
e
o
c
l
a
s
t
-
m
e
d
i
a
t
e
d
 
r
e
s
o
r
p
t
i
o
n
 
Osteocytes
 
express
 
enzymes
 
(cathepsin
 
K,
 
TRAP)
 
and
 
secrete
 
acid,
 
similar
 
to
osteoclasts
Loss
 
of
 
the
 
PTH
 
receptor
 
from
 
osteocytes
 
reduces
 
both
 
osteocytic
 osteolysis
and
 
osteoclast-
mediated
 
bone
 
resorption
Loss
 
of
 
cathepsin
 
K
 
from
 
osteocytes
 
reduces
 
osteocytic
 
osteolysis,
 
osteoclast-
mediated
 
bone
 
resorption,
 
and
 
osteoclast
 
number
Products
 
released
 
from
 
the
 
matrix
 
must
 
signal
 
to
 
osteoclasts;
 
without
 
them,
osteoclast
 
recruitment
 
and
 
activity
 
are
 
reduced
 
during
 lactation
 
Ryan
 
BA
 
and
 
Kovacs
 
CS.
 
J
 
Clin
 
Invest
 
2019;
 
129:3041-
3044
Lotinun
 
S.
 
J
 
Clin
 
Invest
 
2019;
 
129:
 
3058-
3071
Qing
 
H.
 
J
 
Bone
 
Miner
 
Res
 
2012;
 
27:
 
1018-
1029
 
C
a
l
c
i
t
o
n
i
n
 
a
c
t
s
 
a
s
 
a
 
b
r
a
k
e
 
o
n
 
b
o
n
e
 
r
e
s
o
r
p
t
i
o
n
 
d
u
r
i
n
g
 
l
a
c
t
a
t
i
o
n
(
a
t
 
l
e
a
s
t
 
i
n
 
m
i
c
e
)
 
Woodrow
 
JP.
 
Endocrinology
 
2006;
 
147:4010-
4021
 
K
e
y
 
p
o
i
n
t
s
 
a
b
o
u
t
 
l
a
c
t
a
t
i
o
n
 
The
 
neonatal
 
demand
 
for
 
minerals
 
in
 
milk
 
is
 
met
 
largely
 
by
 
maternal 
bone
resorption,
 
independent
 
of
 
dietary
 
calcium
 
intake
 
and
 absorption
 
Low
 
estradiol,
 
in
 
combination
 
with
 
high
 
circulating
 
concentrations
 
of
 
PTHrP
secreted
 
from
 
the
 
lactating
 
breasts,
 
stimulates
 
this
 
bone
 resorption
 
A
 
temporary
 
loss
 
of
 
maternal
 
bone
 
strength
 
is
 
inevitable
 
during
 
lactation,
 
but
for
 
most
 
women
 
this
 
happens
 
silently
 
with
 
no
 
consequences
 
C
a
u
s
e
s
 
o
f
 
s
k
e
l
e
t
a
l
 
f
r
a
g
i
l
i
t
y
 
a
s
s
o
c
i
a
t
e
d
 
w
i
t
h
 
l
a
c
t
a
t
i
o
n
 
Hormonal
Normal
 
or
 
even
 
excess
 
lactational
 
bone
loss,
 
mediated
 
by
 
PTHrP
 
and
 
low
estradiol*
 
Other
Increased
 
breast
 
milk
 
output
 
(e.g.,
nursing
 
twins)
Prolonged
 
duration
 
of
 
exclusive
 
lactation
 
Being
 
a
 
primipara
 
Mechanical
Carrying,
 
bending,
 
and
 
lifting
 
maneuvers
with
 
baby
 
and
 
related
 
paraphernalia
 
All
 
of
 
the
 
factors
 
previously
 
listed
 
for
 
pregnancy,
 
plus:
 
*This
 
PTHrP-mediated
 
skeletal
 
resorption
 
is
 
sufficient
 
to
cause
 
hypercalcemia
 
in
 
some
 
normal
 
breastfeeding
women,
 
and
 
to
 
normalize
 
calcium
 
homeostasis
 
in
hypoparathyroid
 
women
 
while
 
breastfeeding
 
Kovacs
 
CS
 
and
 
Ralston
 
SH.
 
Osteoporos
 
Int
 
2015;
 
26:2223-
2241
 
O
s
t
e
o
p
o
r
o
s
i
s
 
d
u
r
i
n
g
 
l
a
c
t
a
t
i
o
n
 
Occasionally
 
vertebral
 
crush
 
fractures
 
occur
 
during
 
lactation
Sometimes
 
it’s
 
a
 
cascade
 
of
 
6
 
to
 
10
 
spontaneous
 
crush
 
fractures,
 
and
 
these
 
cases
 
get
 
reported
 
in
 
the
 
literature;
 
it’s
 
unknown
 
how
 
common
 
1
 
or
 
2
 
fractures
 
might
 
be
Back
 
pain
 
is
 
common
 post-
partum;
 
compression
 
fractures
 
may
 
be
 
missed
Prepregnancy
 
(baseline)
 
bone
 
density
 
is
 
usually
 unknown
Likely
 
due
 
to
 
bone
 
loss
 
during
 
lactation
 
on
 
top
 
of
 
skeletal
 
losses
 
or
 inherent
fragility
 
that
 
preceded
 
this
 
time
 period
70-
90%
 
of 
reproduction-
associated
 
fractures
 
occur within
 
2-
3
 
months
 
of 
lactation
 
Recommend
 
(my
 
opinion):
Conservative
 
management
 
with
 
expectation
 
that
 
bone
 
mass
 
will
 
increase
 after
weaning;
 
hold
 
off
 
on
 
use
 
of
 
osteoporosis
 
medications
Spontaneous
 
BMD
 
increases
 
of
 
10-20%
 
and
 
up
 
to
 
40%
 
have
 
occurred
Reserve
 
pharmacotherapy
 
for
 
inadequate
 
responders
 
or
 
more
 
severe
 
cases
 
Kovacs
 
CS
 
and
 
Ralston
 
SH.
 
Osteoporos
 
Int
 
2015;
 
26:2223-
2241
 
E
s
t
i
m
a
t
e
s
 
o
f
 
i
n
c
i
d
e
n
c
e
 
o
f
 
o
s
t
e
o
p
o
r
o
s
i
s
 
o
c
c
u
r
r
i
n
g
 
i
n
a
s
s
o
c
i
a
t
i
o
n
 
w
i
t
h
 
p
r
e
g
n
a
n
c
y
 
o
r
 
l
a
c
t
a
t
i
o
n
 
Of
 
1,260
 
thoracic,
 
lumbar,
 
or
 
thoracolumbar
 
MRIs
 
done
 
in
 
women
 
of
reproductive
 
age
 
over
 
2
 
years
 
at
 
one
 
institution,
 
six
 
women
 
(0.47%)
 
had
compression
 
fractures
 
associated
 
with
 
recent
 
pregnancy
 
or
 
lactation
1
Mean
 
of
 
5.6
 
compression
 
fractures
 
per
 
woman
 
Of
 
837,347
 
recent
 
pregnancies,
 
379
 
women
 
(4.5
 
/
 
10,000)
 
presented
 
to
hospital
 
within
 
2
 
years
 
due
 
to
 fractures
2
 
The
 
diagnosis
 
was
 
delayed
 
12
 
weeks
 
from
 
the
 
onset
 
of
 
pain
 
in
 
most
 women
3
Explained
 
away
 
as
 
normal
 
back
 
pain
 
expected
 
during
 
lactation
 
1
 
Yildiz
 
AE.
 
Osteoporos
 
Int
 
2022;
 
32:981-
989
2
 
Toba
 
M.
 
J
 
Bone
 
Miner
 
Metab
 
2017;
 
40:748-
754
3
 
Kondapalli
 
AV.
 
Osteoporos
 
Int
 
2023;
 
34:1477-
1489
 
W
h
e
r
e
 
d
o
 
t
h
e
 
c
o
m
p
r
e
s
s
i
o
n
 
f
r
a
c
t
u
r
e
s
 
o
c
c
u
r
?
 
Hadji
 
P.
 
Geburtshilfe
 
Frauenheilkd
 
2022;
 
82:619-
626
 
Number
 
and
 
location
 
of
 
fractures
 
in
 
47
 
cases
 
followed
 
between
 
2006
 
and
 
2018
 
at
 
one
 
institution
 
in
 
Germany
 
P
o
s
t
-
w
e
a
n
i
n
g
 
b
o
n
e
 
r
e
c
o
v
e
r
y
 
P
o
s
t
-
w
e
a
n
i
n
g
 
s
k
e
l
e
t
a
l
 
r
e
c
o
v
e
r
y
 
Return
 
to
 
baseline
 
BMD
 
and
 
presumed
 
bone
 
strength
 
in
 
six
 
to
 
twelve
 months
for
 
most
 
women
However,
 
there
 
are
 
persistent
 
changes
 
in
 
appendicular
 
microarchitecture
 
seen
 
by
 
HR-
 
pQCT
 
at
 
the
 
radius
 
and
 
tibia
 
(cannot
 
examine
 
spine
 
and
 
hip
 
by
 
this
 
technique)
 
1,2
 
Regulation
 
of
 
skeletal
 
recovery
 
is
 
not
 
understood
 
In
 
the
 long-
term,
 
a
 
history
 
of
 
lactation
 
has
 
a
 
neutral
 
or
 
protective
 
effect
 against
the
 
development
 
of
 
low
 
BMD,
 
osteoporosis,
 
and
 
fragility
 fractures
 
1
 
Brembeck
 
P.
 
J
 
Clin
 
Endocrinol
 
Metab
 
2015;
 
100:535-
543
2
 
Bjornerem
 
A.
 
J
 
Bone
 
Miner
 
Res
 
2017;
 
32:681-
687
Kovacs
 
CS.
 
Physiol
 
Rev
 
2016;
 
96:449-
547
 
E
p
i
d
e
m
i
o
l
o
g
y
 
o
f
 
p
a
r
i
t
y
,
 
l
a
c
t
a
t
i
o
n
,
 
a
n
d
 
o
s
t
e
o
p
o
r
o
s
i
s
 
More
 
than
 
six
 
dozen
 
epidemiological
 
studies
 
have
 
found
 
that
 
parity
 
or
 
lactation
(or
 
both)
 
have
 
a
 
neutral
 
or
 
protective
 
effect
 
on
 
long-
term
 
risk
 
of
 osteoporosis,
fragility
 
fractures,
 
or
 
low
 
BMD
 
A
 
study
 
of
 
1,852
 
twins
 
and
 
their
 
female
 
relatives,
 
including
 
83
 
twins
 
who
 
were
discordant
 
for
 
pregnancy
 
and
 
lactation,
 
found
 
no
 
effect
 
of
 
breastfeeding
 history
on
 
BMD
Parous
 
women
 
who
 
had
 
breastfed
 
had
 
higher
 
BMD
 
than
 
parous
 
women
 
who
 
had
 
never
 
breastfed
 
Paton
 
LM.
 
Am
 
J
 
Clin
 
Nutr
 
2003;
 
77:
 
707-
714
Kovacs
 
CS.
 
Physiol
 
Rev
 
2016;
 
96:449-
547
Segal
 
E.
 
Osteoporos
 
Int
 
2011;
 
22:2907-
2911
 
L
a
c
t
a
t
i
o
n
a
l
 
B
M
D
 
d
e
c
l
i
n
e
 
i
s
 
f
o
l
l
o
w
e
d
 
b
y
 
p
o
s
t
-
w
e
a
n
i
n
g
 
r
e
c
o
v
e
r
y
 
Sowers
 
MF.
 
JAMA
 
1993;
 
269:
 
3130-
3135
 
L
a
c
t
a
t
i
o
n
a
l
 
B
M
D
 
d
e
c
l
i
n
e
 
i
s
 
f
o
l
l
o
w
e
d
 
b
y
 
p
o
s
t
-
w
e
a
n
i
n
g
 
r
e
c
o
v
e
r
y
 
Kalkwarf
 
HJ.
 
Obstet
 
Gynecol
 
1995;
 
86:26-
32
 
S
p
o
n
t
a
n
e
o
u
s
 
B
M
D
 
i
n
c
r
e
a
s
e
 
i
n
 
w
o
m
e
n
 
w
h
o
 
f
r
a
c
t
u
r
e
d
1
3
 
w
o
m
e
n
 
a
t
 
a
 
c
e
n
t
e
r
 
i
n
 
t
h
e
 
U
K
 
Phillips
 
AJ.
 
Osteoporos
 
Int
 
2000;
 
11:449-
454
 
B
o
n
e
 
r
e
c
o
v
e
r
y
 
a
f
t
e
r
 
l
a
c
t
a
t
i
o
n
 
i
n
v
o
l
v
e
s
 
Stimulation
 
of
 
new
 
bone
 
formation
Remineralization
 
of
 
existing
 
bone
around
 osteocytes
Compensatory
 
increase
 
in
 
diameter
of
 
some
 
long
 
bones?
 
Kovacs
 
CS
 
and
 
Ralston
 
SH.
 
Osteoporos
 
Int
 
2015;
 
26:2223-
2241
 
W
h
a
t
 
r
e
g
u
l
a
t
e
s
 
p
o
s
t
-
l
a
c
t
a
t
i
o
n
 
s
k
e
l
e
t
a
l
 
r
e
c
o
v
e
r
y
?
 
In
 
animal
 
models,
 
none
 
of
 
the
 
known
 
calciotropic
 
hormones
 
(“the
 usual
suspects”)
 
are
 
required
 
for
 
full
 
skeletal
 
recovery
 
(bone
 
mass
 
and
 strength)
Includes
 
PTH,
 
calcitriol,
 
VDR,
 
PTHrP,
 
calcitonin,
 
estradiol
 
Limited
 
case
 
reports
 
support
 
these
 
findings,
 
such
 
as
 
a
 
documented
 
40%
increase
 
increase
 
in
 
bone
 
mass
 
after
 
weaning
 
in
 
an
 
aparathyroid
 woman
 
Segal
 
E.
 
Osteoporos
 
Int
 
2011;
 
22:2907–2911
Kovacs
 
CS.
 
Physiol
 
Rev
 
2016;
 
96:449-
547
 
B
o
n
e
 
m
i
n
e
r
a
l
 
c
o
n
t
e
n
t
 
(
B
M
C
)
 
r
e
c
o
v
e
r
s
 
w
i
t
h
o
u
t
 
P
T
H
 
Kirby
 
BJ
 
J
 
Bone
 
Mineral
 
Res
 
2013;
 
28:1987-
2000
 
S
p
o
n
t
a
n
e
o
u
s
 
a
n
d
 
p
o
s
t
-
p
h
a
r
m
a
c
o
t
h
e
r
a
p
y
 
b
o
n
e
 
r
e
c
o
v
e
r
y
 
Individual
 
case
 
reports
 
and
 
series
 
have
 
documented
 
spontaneous
 
BMD
increases
 
of
 10-
20%
 
(one
 
case
 
up
 
to
 
40%)
Pharmacotherapy
 
has
 
been
 
used
 
in
 
case
 
reports
 
and
 
series,
 
with
 reported
BMD increases of
 
10-
30%
Bisphosphonates;
 
denosumab;
 
teriparatide;
 
romosozumab;
 
calcitonin;
 
strontium
 
ranelate;
 
fluoride;
 
calcitriol
 
(none
 
yet
 
with
 
abaloparatide)
There
 
are
 
no
 
randomized
 
trials
 
comparing
 
spontaneous
 
vs.
 
pharmacologically
assisted
 
skeletal
 
recovery
Most
 
case
 
reports
 
simply
 
report
 
the
 
increase
 
in
 
a
 
treated
 
case
 
and
 assume
nothing
 
would
 
have
 
happened
 
without
 pharmacotherapy
 
Kovacs
 
CS
 
and
 
Ralston
 
SH.
 
Osteoporos
 
Int
 
2015;
 
26:2223-
2241
 
W
h
a
t
 
i
s
 
c
o
n
s
e
r
v
a
t
i
v
e
 
m
a
n
a
g
e
m
e
n
t
?
 
Optimize
 
calcium
 
and
 
vitamin
 
D
 
intake,
 
and
 
overall
 
nutrition
Early
 
mobilization;
 
avoid
 bedrest
Encourage
 
weight-
bearing
 
physical activity:
 
must
 
stay 
active
Avoid
 
activities
 
with
 
significant
 
lifting
 
or
 
increased
 
risk
 
of
 
falls
Consider
 
avoiding
 
lactation
 
(with
 
pregnancy
 fractures)
Consider
 
weaning
 
baby
 
(with
 
lactation
 fractures)
Physiotherapy
 
to
 
maintain
 
mobility,
 
improve
 
core
 
muscle
 
strength,
 
reduce
 
pain
Supportive
 
corset
 
(temporary)
 
for
 
vertebral
 
fracture
 pain
Assess
 
spontaneous
 
recovery
 
of
 
vertebral
 
BMD
 
at
 
12–18
 months
 
(Kyphoplasty
 
or
 
vertebroplasty
 
have
 
been
 
done
 
for
 
persistent
 
pain)
 
Kovacs
 
CS
 
and
 
Ralston
 
SH.
 
Osteoporos
 
Int
 
2015;
 
26:2223-
2241
 
C
o
n
s
i
d
e
r
a
t
i
o
n
s
 
a
s
 
t
o
 
w
h
y
 
p
h
a
r
m
a
c
o
t
h
e
r
a
p
y
i
s
n
t
 
t
h
e
 
i
m
m
e
d
i
a
t
e
 
f
i
r
s
t
 
c
h
o
i
c
e
 
A
 
spontaneous
 10-
20%
 
or
 
greater
 
increase
 
may
 
occur:
 
wait
 
to
 
see
 
if
pharmacotherapy
 
is
 
needed
 
(e.g.,
 
unsatisfactory
 
BMD
 regain)
Could
 
pharmacotherapy
 
interfere
 
with
 
natural
 
skeletal
 recovery?
e.g.,
 
anti-resorptives
 
blunting
 
the
 
effect
 
of
 
spontaneous
 
anabolism
The
 
interval
 
of
 
bone
 
loss
 
is
 
over;
 
why
 
treat
 
with
 
agents
 
that
 
stop
 
bone
 
loss?
Anabolics
 
are
 
normally
 
followed
 
by
 
an
 anti-
resorptive
 
or
 
else
 
all gains
 
are
quickly
 
lost
 
within
 
a
 
year
 
or
 
two
What
 
is
 
the
 
end-
point
 
of
 
treatment,
 
and
 
long-
term
 
adverse
 
risks,
 
if
 
an
 
anti-
resorptive
 
is
 
used
 
in
 
young
 women?
Fracture
 
risk
 
should
 
be
 
low
 
and
 
bone
 
mass
 
stable
 
in
 
reproductive
 
age
 
women
All
 
such
 
use
 
is
 off-
label;
 
concerns
 
about
 
teratogenic
 
effects,
 
esp.
 denosumab
 
Kovacs
 
CS
 
and
 
Ralston
 
SH.
 
Osteoporos
 
Int
 
2015;
 
26:2223-
2241
 
I
f
 
p
h
a
r
m
a
c
o
t
h
e
r
a
p
y
 
i
s
 
n
e
e
d
e
d
,
 
w
h
i
c
h
 
t
o
 
c
h
o
o
s
e
?
 
Anabolic
 
treatment
 
makes
 
the
 
most
 
sense
 
to
 
increase
 
bone
 
mass
 
and
 strength
if
 
spontaneous
 
recovery
 
is
 
judged
 inadequate
Anti-remodeling
 
agents
 
may
 
not
 
be
 
needed:
 
case
 
reports
 
suggest
 
that
 
anabolic-
 
induced
 
gains
 
in
 
BMD
 
may
 
be
 
maintained
 
in
 
reproductive-age
 
women
 
If
 
anabolics
 
cannot
 
be
 
used
 
or
 
afforded,
 
then
 
anti-
remodeling
 
agents
(bisphosphonates,
 
denosumab)
 
may
 
be
 considered
Perhaps
 
earlier
 
in
 
the
 
post-weaning
 
phase
 
when
 
spontaneous
 
anabolism
 
is
 
occurring,
 
assuming
 
that
 
their
 
use
 
does
 
not
 
interfere
 
with
 
normal
 
skeletal
 
recovery
 
Kovacs
 
CS
 
and
 
Ralston
 
SH.
 
Osteoporos
 
Int
 
2015;
 
26:2223-
2241
 
2
4
 
m
o
n
t
h
s
 
o
f
 
t
e
r
i
p
a
r
a
t
i
d
e
 
a
n
d
 
1
 
y
e
a
r
 
f
o
l
l
o
w
-
u
p
 
i
n
 
4
7
 
c
a
s
e
s
 
Hadji
 
P.
 
Geburtshilfe
 
Frauenheilkd
 
2022;
 
82:619-
626
 
Treated
 
between
 
2006
 
and
 
2018
 
at
 
one
 
institution
 
in
 
Germany
Afterwards,
 
all
 
women
 
had
 
regular
 
menses
 
or
 
took
 
oral
 
contraceptives
 
1
0
7
 
p
a
t
i
e
n
t
s
 
a
t
 
o
n
e
 
c
e
n
t
e
r
 
i
n
 
G
e
r
m
a
n
y
,
 
7
6
%
 
t
r
e
a
t
e
d
 
Kyvernitakis
 
I…
 
Hadji
 
P.
 
Osteoporos
 
In
t
 
2018;
 
29:135-
142
Untreated
 
patients
 
from
 
UK
 
in
Phillips
 
AJ.
 
Osteoporos
 
Int
 
2000;
 
11:
 
449-
454
 
Followed
 
between
 
2004
 
and
 
2014
 
at
 
one
 
institution
 
in
 
Germany
 
25%
 
(26/107)
 
women
 
fractured
 
during
 
median
 
6
 
years
 
of
 
follow-
up
Twice
 
as
 
many
 
fractures
 
occurred
 
in
 
those
 
treated
 
with
 
bisphosphonates,
 
teriparatide,
 
or
 
both
 
as
compared
 
to
 
those
 
who
 
were
 
not
 
treated
20%
 
(6/30)
 
women
 
fractured
 
during
 
a
 
subsequent
 
pregnancy/lactation
 
cycle
Provided
 
4.5-year
 
follow-up
 
BMD
 
on
 
13
 
women
 
who
 
had
 
been
 
treated:
 
C
a
s
e
 
P
r
e
s
e
n
t
a
t
i
o
n
 
-
 
5
 
High
 
phytate
 
intake
 
meant
 
her
 
calcium
 
absorption
 
was
 
lower
 
than
 
implied
 
by
her
 
habitual
 
750
 
mg
 
intake
 
and
 
her
 
1000
 
mg
 
intake
 
during
 
pregnancy
Therefore,
 
she
 
likely
 
lost
 
significant
 
bone
 
mass
 
during
 
pregnancy
 
Pumping
 
and
 
discarding
 
milk
 
meant
 
she
 
produced
 
twice
 
as
 
much
 
milk
 
as
needed,
 
and
 
likely
 
lost
 
twice
 
as
 
much
 
bone
 
mineral
 
content
 
as
 
needed
She
 
was
 
effectively
 
nursing
 
twins!
She
 
definitely
 
lost
 
more
 
bone
 
mass
 
than
 
expected
 
during
 
lactation
 
C
a
s
e
 
P
r
e
s
e
n
t
a
t
i
o
n
 
-
 
6
 
Initially
 
treated
 
conservatively
 
and
 
continued
 
to
 
breastfeed
Ongoing
 
significant
 
back
 
pain
Gradually
 
weaned
 
the
 
baby
 
by
 
9
 
months
 
postpartum
HR-
pQCT
 
scan
 
seven
 
months
 
after
 
baseline
 
scan
 
(15
 
months
 
postpartum
 
and
six
 
months
 
postweaning)
 
showed
 
no
 
improvement
 
in
 
any
 parameter
But
 
post-weaning
 
changes
 
lag
 
on
 
HR-pQCT
 
and
 
are
 
threshold
 
dependent
New
 
bone
 
that
 
is
 
not
 
fully
 
mineralized
 
will
 
not
 
be
 
detected
Started
 
treatment
 
with
 
teriparatide
 
(Forteo)
 
beginning
 
around
 
16
 
months
postpartum
 
or
 
seven
 
months
 
after
 
weaning
Several
 
stops
 
and
 
starts
 
due
 
to
 
exacerbations
 
of
 
bone
 
pain
 
but
 
she
 ultimately
received
 
about
 
14
 
months
 
of
 
teriparatide
 
over
 
18
 months
 
C
a
s
e
 
P
r
e
s
e
n
t
a
t
i
o
n
 
-
 
7
 
A
 
repeat
 
Lunar
 
DXA
 
scan
 
done
 
13
 
months
 
into
 
treatment
 
on
 
the
 
original 
device
showed:
50%
 
increase
 
in
 
the
 
lumbar
 
spine
 
to
 
0.968
 
g/cm
2
 
or
 
Z-score
 
of
 
-
0.6
8%
 
increase
 
in
 
the
 
total
 
hip
 
to
 
0.797
 
g/cm
2
 
or
 
a
 
Z-score
 
of
 
-
1.1.
13%
 
increase
 
in
 
femoral
 
neck
 
to
 
0.612
 
g/cm
2
 
or
 
a
 
Z-score
 
of
 
-
1.9.
 
After
 
teriparatide,
 
she
 
tentatively
 
agreed
 
to
 
one-
year
 
treatment
 
with
 risedronate
to
 
consolidate
 
the
 
bone
 
gains,
 
but
 
did
 
not
 
take
 
any
 
of
 
it
 
She
 
moved
 
to
 
Newfoundland
 
and
 
asked
 
me
 
to
 
prognosticate
 
about
 
her
 
risks
 
for
another
 
pregnancy
 
C
a
s
e
 
P
r
e
s
e
n
t
a
t
i
o
n
 
-
 
8
 
On
 
a
 
different
 
Lunar
 
DXA,
 
one
 
year
 
after
 
teriparatide
 completed:
L1-L4
 
spine
 
was
 
1.139
 
g/cm
2
 
or
 
Z-score
 
of
 
-
0.3
Total
 
hip
 
was
 
0.790
 
g/cm
2
 
or
 
Z-score
 
of
 
-
1.7
Femoral
 
neck
 
was
 
0.765
 
g/cm
2
 
or
 
Z-score
 
of
 
-
1.6
 
These
 
DXA
 
readings
 
are
 
not
 
directly
 
comparable
 
to
 
prior
 
results,
 
but
 
stability
 
of
bone
 
mass
 
is
 
suggested
Her
 
peak
 
BMD
 
response
 
from
 
teriparatide
 
is
 
unknown
 
due
 
to
 
the
 
timing
 
FRAX
 
score
 
4.3%
 
with
 
1.0%
 
risk
 
of
 
hip
 
fractures
Or
 
5.6%
 
with
 
adjustment
 
for
 
3
 
or
 
more
 
prior
 
fractures
 
C
o
n
c
l
u
s
i
o
n
s
 
Intestinal
 
calcium
 
absorption
 
doubles
 
during
 
pregnancy
 
to
 
meet
 
the
 fetal
demand
 
for
 
calcium
The
 
maternal
 
skeleton
 
is
 
resorbed
 
during
 
lactation
 
to
 
provide
 
much
 
of
 
the
calcium
 
content
 
of
 
breast
 
milk
Osteoporosis
 
can
 
present
 
during
 
pregnancy
 
or
 
lactation
 
because
 
of
 
underlying
skeletal
 
fragility,
 
inadequate
 
net
 
calcium
 
absorption
 
during
 pregnancy,
increased
 
skeletal
 
resorption
 
during
 
lactation,
 
and
 
other
 
factors
Conservative
 
management
 
is
 
recommended
 
first
 
to
 
allow
 spontaneous
recovery
 
to
 
occur
Pharmacotherapy
 
is
 
reserved
 
for
 
more
 
severe
 
cases
 
and
 
especially
 
those
 
who
fail
 
to
 
show
 
substantial
 
spontaneous
 recovery
Slide Note
Embed
Share

Dr. Christopher Kovacs presents three intriguing case studies related to osteoporosis associated with pregnancy and lactation. The cases showcase the impact of various factors such as inadequate milk production, medication use, dietary habits, and familial history on bone health. These cases highlight the importance of comprehensive care and awareness in managing osteoporosis in women during and after pregnancy.

  • Osteoporosis
  • Pregnancy
  • Lactation
  • Case Study
  • Bone Health

Uploaded on Mar 19, 2024 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. Osteoporosis Associated with Pregnancy and Lactation Christopher Kovacs, MD, FRCPC, FACP, FACE University Research Professor Professor of Medicine (Endocrinology), Obstetrics & Gynecology, and BioMedical Sciences Faculty of Medicine - Endocrinology Memorial University of Newfoundland ckovacs@mun.ca

  2. Disclosure No relevant conflicts of interest This area is both a clinical interest and a research focus for me

  3. Case Presentation - 1 Age 35 with ankylosing spondylitis, treated with a TNF blocker Uneventful first pregnancy and began breastfeeding Lactation consultant advised that baby s slow weight gain meant inadequate milk production Instructed her to pump in between feeds and store (not use) the milk (!) Pumped and stored as much milk as her baby received directly through nursing Two months into breastfeeding, felt increasing back pain Rheumatologist adjusted her meds but no relief from pain Bent over to move her baby in the car seat: felt and heard a loud crack in her back Presented to orthopedics and referred to endocrinology in Calgary Disclosed when I saw her several years later

  4. Case Presentation - 2 Spine radiographs showed compression fractures of 30% at T11 and 40% at T12, accompanied by endplate depressions at L2, L3 and L4 (These radiographs were done several years later at my institution)

  5. Case Presentation - 3 Vegetarian with high phytate intake Habitual calcium intake of 750 mg daily; 250 mg supplement during pregnancy to reach 1,000 mg daily (vs. 1,200 mg optimal intake) Habitual vitamin D intake 3,800 IU daily through supplements Determined when I saw her several years later Ulnar fracture at age 12 when she was pushed down on the schoolyard Ankle fracture at age 17 when she fell downstairs Twice she had 3-week courses of prednisone for asthma (15 mg starting dose) Attention deficit hyperactivity disorder, postpartum depression, iron deficiency, mild psoriasis, periodic vertigo Sister has low bone mass ( osteopenia ) but no fractures

  6. Case Presentation - 4 Workup for secondary causes of bone loss was otherwise unremarkable Whole genome sequencing found no mutations in any genes related to osteoporosis, bone mass, or bone metabolism At 6 months postpartum, while still breastfeeding, Lunar DXA revealed severe bone loss at the lumbar spine: Lumbar spine 0.645 g/cm2 or Z-score -3.6 Total hip 0.736 g/cm2 or Z-score -1.6 Femoral neck 0.542 g/cm2 or Z-score -2.6 At 8 months postpartum, HR-pQCT showed very low trabecular bone volumes in the left radius and tibia

  7. Pregnancy

  8. Mineral demands during pregnancy Average human fetus at term has: 30 g of calcium 20 g of phosphorus 0.8 g of magnesium 80% is accreted during the third trimester The rate of accretion averages 150 mg calcium per kg fetal weight daily 60 mg per day at week 24 300-350 mg per day between the 35th and 40th weeks Kovacs CS. Physiol Rev 2016; 96:449-547

  9. The potential calcium deficit Recommended calcium intake (non-pregnant or pregnant) is 1,200 mg per day In reproductive age North American women: 50th percentile of calcium intake is ~800-1,000 mg daily (varying by age and ethnicity)* ~25% of dietary calcium is absorbed Net absorption is 200-250 mg of calcium This is insufficient to meet the fetal demands in the third trimester, and well below the combined requirements of mother and fetus Assuming 25% absorption, would require an extra 1,400 mg daily to provide the 350 mg the fetus needs during the late third trimester Institute of Medicine, Dietary Reference Intakes for Calcium and Vitamin D, 2011 *NHANES and Health Canada data Kovacs CS. Physiol Rev 2016; 96:449-547

  10. Maternal adaptations during pregnancy 80% of calcium is actively transported to the fetus in third trimester Doubling of intestinal calcium absorption begins in 1st trimester Calcium balance studies predict maternal skeletal mineral content must be increased during the first half of pregnancy Concurrent 2 to 5-fold increase in calcitriol (active vitamin D) Kovacs CS. Physiol Rev 2016; 96:449-547

  11. Calcium Intake Pregnancy Serum calcium falls due to albumin Ionized calcium normal PTH low* Calcitriol increases 2 to 5-fold PTHrP increases steadily Estradiol increases up to 100x Calcitonin increased Serum Ca++ Urine Intestinal calcium absorption doubled *exception: women from Asia and Africa with very low calcium or high phytate intakes PTHrP = PTH-related protein Kovacs CS and Kronenberg HM. Endocr Rev 1997; 18:832-872

  12. Maternal kidneys not placenta are the source of calcitriol during pregnancy in rodents and women Anephric women have low, unchanging calcitriol before and during pregnancy1 In mice, maternal absence of Cyp27b1 (the enzyme that creates calcitriol) obliterates the rise in calcitriol2 1Turner M. Miner Electrolyte Metab 1988; 14:246-252 2Gillies B. J Bone Miner Res 2018; 33:16-26

  13. Calcitriol increases during pregnancy without PTH Inferred that calcitriol rises during pregnancy in hypoparathyroid women in whom supplemental calcitriol needs are reduced or eliminated Confirmed in aparathyroid rodents, including mice lacking the gene encoding PTH Sweeney L. Endocr Pract. 2010; 16:459-462 Kovacs CS. Physiol Rev 2016; 96:449-547 Kirby BJ. J Bone Mineral Res 2013; 28:1987-2000

  14. Intestinal calcium absorption increases during pregnancy in rodents without calcitriol, VDR, or vitamin D Kovacs CS. Physiol Rev 2016; 96:449-547 Ryan BA. J Bone Miner Res 2022; 36: 2483-2497

  15. Key points about pregnancy The fetal demand for mineral is met by increased intestinal absorption But if net calcium intake is low, the maternal skeleton must be resorbed The increase in calcium absorption is driven in part by an increase in calcitriol, but it s also driven by unknown factors independent of calcitriol More than one mechanism kicks in to ensure calcium delivery Consequently, calcium delivery is maintained despite severe vitamin D deficiency

  16. Causes of skeletal fragility associated with pregnancy Nutritional Low dietary calcium intake Dairy avoidance Lactose intolerance Low vitamin D intake/vitamin D deficiency High phytate intake Anorexia nervosa Hormonal Excess PTHrP from placenta or breasts* Primary hyperparathyroidism Hyperthyroidism Cushing s syndrome Chronic oligoamenorrhea Hypothalamic amenorrhea Pituitary disorders leading to sex steroid deficiency Premature ovarian failure Gastrointestinal Celiac disease Crohn s disease Cystic fibrosis Short bowel from resections Other malabsorptive disorders *each source has also been found to cause hypercalcemia in pregnancy Kovacs CS and Ralston SH. Osteoporos Int 2015; 26:2223-2241

  17. Causes of skeletal fragility associated with pregnancy Mechanical Petite frame Low body weight Low peak bone mass Excess exercise Increased weight-bearing of pregnancy Lordotic posture of pregnancy Bedrest Incomplete recovery from prior lactation? Pharmacological GnRH analog treatment Progestin-only contraceptives Glucocorticoids Proton pump inhibitors Heparin Certain anti-seizure medications (phenytoin, carbamazepine) Cancer chemotherapy Alcohol Renal Hypercalciuria/renal calcium leak Chronic renal insufficiency Renal tubular acidosis Kovacs CS and Ralston SH. Osteoporos Int 2015; 26:2223-2241

  18. Causes of skeletal fragility associated with pregnancy Primary disorders of bone quality* Osteogenesis imperfecta (COL1A1/1A2 mutations) milder forms Osteopetrosis and other sclerosing bone disorders LRP5 inactivating mutations Wnt1 mutations Rheumatological disorders Rheumatoid arthritis Systemic lupus erythematosis Other non-specified genetic disorders Family history of osteoporosis or skeletal fragility Positive genetic screen for other bone disorders Connective tissue disorders Ehlers-Danlos syndrome Marfan syndrome Idiopathic osteoporosis Being a primipara *not known prior to pregnancy Kovacs CS and Ralston SH. Osteoporos Int 2015; 26:2223-2241

  19. Osteoporosis presenting during pregnancy Occasionally vertebral crush fractures occur during late pregnancy Exact frequency unknown Back pain is common during pregnancy; compression fractures may be overlooked Some evidence that appendicular fractures may be more common1 Baseline or pre-pregnancy bone mineral density (BMD) usually unknown May be due to a combination of factors shown on preceding three slides Recommend (my opinion): Conservative management and postpartum investigations into bone health Expect a spontaneous postpartum increase in BMD by 10-20% May be advisable to avoid breastfeeding 1 Herath M. Arch Osteoporos 2017; 12: 86 Kovacs CS and Ralston SH. Osteoporos Int 2015; 26:2223-2241

  20. Separate disorder: transient osteoporosis of the hip AKA localized or regional migratory osteoporosis; bone marrow edema syndrome Not due to systemic resorption of the skeleton A form of chronic regional pain syndrome type I or reflex sympathetic dystrophy Can occur equally in men and non-pregnant women Women present during the third trimester or early postpartum with hip pain, limp, or hip fracture; occasionally, both hips are involved Radiographs show osteopenia and radiolucency of femoral head and neck DXA shows low hip BMD whereas spine is normal or not as reduced MRI shows edema of femoral head and marrow DXA and MRI findings typically resolve within 2 to 12 months; BMD may increase by 20-40% Kovacs CS and Ralston SH. Osteoporos Int 2015; 26:2223-2241

  21. Lactation

  22. Lactation Neonate requires an average of 210 mg of calcium daily through milk during the first six months Between 6 to 12 months the infant requires about 260 mg of calcium daily 120 mg per day from milk 140 mg from solid foods Nursing twins or triplets respectively doubles and triples the maternal calcium output Maternal intake and absorption of calcium is typically insufficient to meet the demands of milk production but it doesn t matter Kovacs CS. Physiol Rev 2016; 96:449-547

  23. Maternal adaptations during lactation Temporary loss of bone mineral to provide ~210 mg calcium daily to milk 5-10% loss of BMD in 2-6 months for women trabecular > cortical vertebral > appendicular Renal calcium conservation Intestinal calcium absorption is normal (non-pregnant rate) Kovacs CS. Physiol Rev 2016; 96:449-547

  24. Greater decline in BMD with longer duration of lactation More C. Osteoporos Int 2001; 12:732-737

  25. Randomized intervention: 1 gram of supplemental calcium does not prevent lactational bone loss Kalkwarf H. N Engl J Med 1997; 337:523-8.

  26. Lactation Calcium Intake Serum calcium normal Ionized calcium normal or slightly increased PTH low Calcitriol normal PTHrP increased Calcitonin increased for first six weeks, then normalizes Estradiol low Prolactin elevated Serum Ca++ Urine Breast Milk Kovacs CS and Kronenberg HM. Endocr Rev 1997; 18:832-872

  27. Brain, breast and bone circuit GnRH LH, FSH E2, PROG OT PRL PTHrP and low estradiol (and possibly additional factors) drive bone resorption during lactation Ca2+ Ca2+ Ca2+ CT Ca2+ Ca2+ Ca2+ PTHrP Ca2+ CT = calcitonin E2= estradiol OT = oxytocin PRL = prolactin PROG = progesterone Kovacs CS. J Mammary Gland Biol Neoplasia 2005; 10:105-118

  28. Hormonal changes drive osteoclast-mediated bone resorption and osteocytic osteolysis Ryan BA and Kovacs CS. J Clin Invest 2019; 129: 3041-3044

  29. Osteocytic osteolysis controls osteoclast-mediated resorption Osteocytes express enzymes (cathepsin K, TRAP) and secrete acid, similar to osteoclasts Loss of the PTH receptor from osteocytes reduces both osteocytic osteolysis and osteoclast-mediated bone resorption Loss of cathepsin K from osteocytes reduces osteocytic osteolysis, osteoclast- mediated bone resorption, and osteoclast number Products released from the matrix must signal to osteoclasts; without them, osteoclast recruitment and activity are reduced during lactation Ryan BA and Kovacs CS. J Clin Invest 2019; 129:3041-3044 Lotinun S. J Clin Invest 2019; 129: 3058-3071 Qing H. J Bone Miner Res 2012; 27: 1018-1029

  30. Calcitonin acts as a brake on bone resorption during lactation (at least in mice) Woodrow JP. Endocrinology 2006; 147:4010-4021

  31. Key points about lactation The neonatal demand for minerals in milk is met largely by maternal bone resorption, independent of dietary calcium intake and absorption Low estradiol, in combination with high circulating concentrations of PTHrP secreted from the lactating breasts, stimulates this bone resorption A temporary loss of maternal bone strength is inevitable during lactation, but for most women this happens silently with no consequences

  32. Causes of skeletal fragility associated with lactation All of the factors previously listed for pregnancy, plus: Hormonal Normal or even excess lactational bone loss, mediated by PTHrP and low estradiol* Mechanical Carrying, bending, and lifting maneuvers with baby and related paraphernalia Other Increased breast milk output (e.g., nursing twins) Prolonged duration of exclusive lactation *This PTHrP-mediated skeletal resorption is sufficient to cause hypercalcemia in some normal breastfeeding women, and to normalize calcium homeostasis in hypoparathyroid women while breastfeeding Being a primipara Kovacs CS and Ralston SH. Osteoporos Int 2015; 26:2223-2241

  33. Osteoporosis during lactation Occasionally vertebral crush fractures occur during lactation Sometimes it s a cascade of 6 to 10 spontaneous crush fractures, and these cases get reported in the literature; it s unknown how common 1 or 2 fractures might be Back pain is common post-partum; compression fractures may be missed Prepregnancy (baseline) bone density is usually unknown Likely due to bone loss during lactation on top of skeletal losses or inherent fragility that preceded this time period 70-90% of reproduction-associated fractures occur within 2-3 months of lactation Recommend (my opinion): Conservative management with expectation that bone mass will increase after weaning; hold off on use of osteoporosis medications Spontaneous BMD increases of 10-20% and up to 40% have occurred Reserve pharmacotherapy for inadequate responders or more severe cases Kovacs CS and Ralston SH. Osteoporos Int 2015; 26:2223-2241

  34. Estimates of incidence of osteoporosis occurring in association with pregnancy or lactation Of 1,260 thoracic, lumbar, or thoracolumbar MRIs done in women of reproductive age over 2 years at one institution, six women (0.47%) had compression fractures associated with recent pregnancy or lactation1 Mean of 5.6 compression fractures per woman Of 837,347 recent pregnancies, 379 women (4.5 / 10,000) presented to hospital within 2 years due to fractures2 The diagnosis was delayed 12 weeks from the onset of pain in most women3 Explained away as normal back pain expected during lactation 1 Yildiz AE. Osteoporos Int 2022; 32:981-989 2 Toba M. J Bone Miner Metab 2017; 40:748-754 3 Kondapalli AV. Osteoporos Int 2023; 34:1477-1489

  35. Where do the compression fractures occur? Number and location of fractures in 47 cases followed between 2006 and 2018 at one institution in Germany Hadji P. Geburtshilfe Frauenheilkd 2022; 82:619-626

  36. Post-weaning bone recovery

  37. Post-weaning skeletal recovery Return to baseline BMD and presumed bone strength in six to twelve months for most women However, there are persistent changes in appendicular microarchitecture seen by HR- pQCT at the radius and tibia (cannot examine spine and hip by this technique) 1,2 Regulation of skeletal recovery is not understood In the long-term, a history of lactation has a neutral or protective effect against the development of low BMD, osteoporosis, and fragility fractures 1 Brembeck P. J Clin Endocrinol Metab 2015; 100:535-543 2 Bjornerem A. J Bone Miner Res 2017; 32:681-687 Kovacs CS. Physiol Rev 2016; 96:449-547

  38. Epidemiology of parity, lactation, and osteoporosis More than six dozen epidemiological studies have found that parity or lactation (or both) have a neutral or protective effect on long-term risk of osteoporosis, fragility fractures, or low BMD A study of 1,852 twins and their female relatives, including 83 twins who were discordant for pregnancy and lactation, found no effect of breastfeeding history on BMD Parous women who had breastfed had higher BMD than parous women who had never breastfed Paton LM. Am J Clin Nutr 2003; 77: 707-714 Kovacs CS. Physiol Rev 2016; 96:449-547 Segal E. Osteoporos Int 2011; 22:2907-2911

  39. Lactational BMD decline is followed by post-weaning recovery Sowers MF. JAMA 1993; 269: 3130-3135

  40. Lactational BMD decline is followed by post-weaning recovery Kalkwarf HJ. Obstet Gynecol 1995; 86:26-32

  41. Spontaneous BMD increase in women who fractured 13 women at a center in the UK Phillips AJ. Osteoporos Int 2000; 11:449-454

  42. Bone recovery after lactation involves Stimulation of new bone formation Remineralization of existing bone around osteocytes Compensatory increase in diameter of some long bones? Kovacs CS and Ralston SH. Osteoporos Int 2015; 26:2223-2241

  43. What regulates post-lactation skeletal recovery? In animal models, none of the known calciotropic hormones ( the usual suspects ) are required for full skeletal recovery (bone mass and strength) Includes PTH, calcitriol, VDR, PTHrP, calcitonin, estradiol Limited case reports support these findings, such as a documented 40% increase increase in bone mass after weaning in an aparathyroid woman Segal E. Osteoporos Int 2011; 22:2907 2911 Kovacs CS. Physiol Rev 2016; 96:449-547

  44. Bone mineral content (BMC) recovers without PTH Kirby BJ J Bone Mineral Res 2013; 28:1987-2000

  45. Spontaneous and post-pharmacotherapy bone recovery Individual case reports and series have documented spontaneous BMD increases of 10-20% (one case up to 40%) Pharmacotherapy has been used in case reports and series, with reported BMD increases of 10-30% Bisphosphonates; denosumab; teriparatide; romosozumab; calcitonin; strontium ranelate; fluoride; calcitriol (none yet with abaloparatide) There are no randomized trials comparing spontaneous vs. pharmacologically assisted skeletal recovery Most case reports simply report the increase in a treated case and assume nothing would have happened without pharmacotherapy Kovacs CS and Ralston SH. Osteoporos Int 2015; 26:2223-2241

  46. What is conservative management? Optimize calcium and vitamin D intake, and overall nutrition Early mobilization; avoid bedrest Encourage weight-bearing physical activity: must stay active Avoid activities with significant lifting or increased risk of falls Consider avoiding lactation (with pregnancy fractures) Consider weaning baby (with lactation fractures) Physiotherapy to maintain mobility, improve core muscle strength, reduce pain Supportive corset (temporary) for vertebral fracture pain Assess spontaneous recovery of vertebral BMD at 12 18 months (Kyphoplasty or vertebroplasty have been done for persistent pain) Kovacs CS and Ralston SH. Osteoporos Int 2015; 26:2223-2241

  47. Considerations as to why pharmacotherapy isn t the immediate first choice A spontaneous 10-20% or greater increase may occur: wait to see if pharmacotherapy is needed (e.g., unsatisfactory BMD regain) Could pharmacotherapy interfere with natural skeletal recovery? e.g., anti-resorptives blunting the effect of spontaneous anabolism The interval of bone loss is over; why treat with agents that stop bone loss? Anabolics are normally followed by an anti-resorptive or else all gains are quickly lost within a year or two What is the end-point of treatment, and long-term adverse risks, if an anti- resorptive is used in young women? Fracture risk should be low and bone mass stable in reproductive age women All such use is off-label; concerns about teratogenic effects, esp. denosumab Kovacs CS and Ralston SH. Osteoporos Int 2015; 26:2223-2241

  48. If pharmacotherapy is needed, which to choose? Anabolic treatment makes the most sense to increase bone mass and strength if spontaneous recovery is judged inadequate Anti-remodeling agents may not be needed: case reports suggest that anabolic- induced gains in BMD may be maintained in reproductive-age women If anabolics cannot be used or afforded, then anti-remodeling agents (bisphosphonates, denosumab) may be considered Perhaps earlier in the post-weaning phase when spontaneous anabolism is occurring, assuming that their use does not interfere with normal skeletal recovery Kovacs CS and Ralston SH. Osteoporos Int 2015; 26:2223-2241

  49. 24 months of teriparatide and 1 year follow-up in 47 cases Treated between 2006 and 2018 at one institution in Germany Afterwards, all women had regular menses or took oral contraceptives Hadji P. Geburtshilfe Frauenheilkd 2022; 82:619-626

  50. 107 patients at one center in Germany, 76% treated Followed between 2004 and 2014 at one institution in Germany 25% (26/107) women fractured during median 6 years of follow-up Twice as many fractures occurred in those treated with bisphosphonates, teriparatide, or both as compared to those who were not treated 20% (6/30) women fractured during a subsequent pregnancy/lactation cycle Provided 4.5-year follow-up BMD on 13 women who had been treated: Untreated patients from UK in Phillips AJ. Osteoporos Int 2000; 11: 449-454 Kyvernitakis I Hadji P. Osteoporos Int 2018; 29:135-142

Related


More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#